Year: 2009

On July 6, 2009, a report of the the U.S.-Japan Regulatory Reform and Competition Policy Initiative was presented to President Obama and Prime Minister Aso of Japan. The report provides an insight into the degree that the U.S. government tries to influence prices for medicines and medical devices in foreign markets. Here, as in other foreign markets, the U.S. government seeks to raise prices, and to give industry an even greater role in setting the prices for their products.

Continue Reading →

According to a report by Duff Wilson in the Sunday New York Times, Much of PhRMA’s $150 million in advertising will be spent pushing Senator Baucus’s version of the health “reform” legislation.

Continue Reading →

USTR has a system I was not that familiar with. For documents the public can’t see, USTR provides access under an NDA to private sector “experts” they want to consult. On Friday I was told by USTR:

“We’ve consulted with an array of experts from various IP and tech industries and associations and NGOs in the process of deliberation regarding a US proposal on one section of the agreement.”

Continue Reading →

James K. Glassman and I published an article on biogenerics today in Roll Call. Continue Reading →

On Saturday, KEI filed comments with the WHO EWG’s 2nd web based hearing. Our comments focused on the criteria for new proposals. Continue Reading →

The web page for the Berkeley workshop on the Google Book Settlement is here. Much of the documentation about the settlement is available here. http://thepublicindex.org/

The agreed upon twitter hash tag seems to be: #gbsfia Continue Reading →